Fisher Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
|
|||||
|
2025
Q1 | $14.9M | Buy |
|
|||||
|
2024
Q4 | $12M | Buy |
|
|||||
|
2024
Q3 | $12.6M | Sell |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $11.5M | Buy |
|
|||||
|
2023
Q4 | $10.9M | Buy |
|
|||||
|
2023
Q3 | $9.16M | Sell |
|
|||||
|
2023
Q2 | $10.4M | Buy |
|
|||||
|
2023
Q1 | $8.64M | Buy |
|
|||||
|
2022
Q4 | $7.53M | Buy |
|
|||||
|
2022
Q3 | $7.41M | Sell |
|
|||||
|
2022
Q2 | $7.4M | Buy |
|
|||||
|
2022
Q1 | $6.42M | Sell |
|
|||||
|
2021
Q4 | $5.55M | Buy |
|
|||||
|
2021
Q3 | $4.37M | Sell |
|
|||||
|
2021
Q2 | $5.04M | Sell |
|
|||||
|
2021
Q1 | $5.6M | Buy |
|
|||||
|
2020
Q4 | $5.87M | Buy |
|
|||||
|
2020
Q3 | $6.66M | Buy |
|
|||||
|
2020
Q2 | $6.77M | Sell |
|
|||||
|
2020
Q1 | $5.65M | Buy |
|
|||||
|
2019
Q4 | $4.89M | Buy |
|
|||||
|
2019
Q3 | $3.75M | Buy |
|
|||||
|
2019
Q2 | $4.01M | Buy |
|
|||||
|
2019
Q1 | $2.79M | Buy |
|
|||||
|
2018
Q4 | $401K | Buy |
|
|||||
|
2018
Q3 | $424K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $763K | Buy |
|
|||||
|
2017
Q3 | $758K | Sell |
|
|||||
|
2017
Q2 | $766K | Buy |
|
|||||
|
2017
Q1 | $570K | Buy |
|
|||||
|
2016
Q4 | $381K | Hold |
|
|||||
|
2016
Q3 | $451K | Buy |
|
|||||
|
2016
Q2 | $461K | Sell |
|
|||||
|
2016
Q1 | $421K | Sell |
|
|||||
|
2015
Q4 | $697K | Buy |
|
|||||
|
2015
Q3 | $513K | Buy |
|
|||||
|
2015
Q2 | $541K | Sell |
|
|||||
|
2015
Q1 | $517K | Buy |
|
|||||
|
2014
Q4 | $520K | Sell |
|
|||||
|
2014
Q3 | $516K | Sell |
|
|||||
|
2014
Q2 | $639K | Buy |
|